BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27164275)

  • 1. Cancer randomized trials showed that dissemination bias is still a problem to be solved.
    Urrútia G; Ballesteros M; Djulbegovic B; Gich I; Roqué M; Bonfill X
    J Clin Epidemiol; 2016 Sep; 77():84-90. PubMed ID: 27164275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Publication of Randomized Clinical Trials in Pediatric Research: A Follow-up Study.
    Crockett LK; Okoli GN; Neilson CJ; Rabbani R; Abou-Setta AM; Klassen TP
    JAMA Netw Open; 2018 May; 1(1):e180156. PubMed ID: 30646048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Publication bias in the anesthesiology literature.
    De Oliveira GS; Chang R; Kendall MC; Fitzgerald PC; McCarthy RJ
    Anesth Analg; 2012 May; 114(5):1042-8. PubMed ID: 22344237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpublication Rates and Characteristics of Registered Randomized Clinical Trials in Digital Health: Cross-Sectional Analysis.
    Al-Durra M; Nolan RP; Seto E; Cafazzo JA; Eysenbach G
    J Med Internet Res; 2018 Dec; 20(12):e11924. PubMed ID: 30485832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials.
    Johnson AL; Fladie I; Anderson JM; Lewis DM; Mons BR; Vassar M
    JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):176-182. PubMed ID: 31876933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
    Rasmussen N; Lee K; Bero L
    Trials; 2009 Dec; 10():116. PubMed ID: 20015404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Language and Indexing Biases Among Chinese-Sponsored Randomized Clinical Trials.
    Jia Y; Huang D; Wen J; Wang Y; Rosman L; Chen Q; Robinson KA; Gagnier JJ; Ehrhardt S; Celentano DD
    JAMA Netw Open; 2020 May; 3(5):e205894. PubMed ID: 32463469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Publication bias of randomized controlled trials in emergency medicine.
    Ospina MB; Kelly K; Klassen TP; Rowe BH
    Acad Emerg Med; 2006 Jan; 13(1):102-8. PubMed ID: 16365332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the publication of randomized controlled trials in child health research.
    Hartling L; Craig WR; Russell K; Stevens K; Klassen TP
    Arch Pediatr Adolesc Med; 2004 Oct; 158(10):983-7. PubMed ID: 15466687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results.
    Suñé P; Suñé JM; Montoro JB
    PLoS One; 2013; 8(1):e54583. PubMed ID: 23382919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Publication bias in trials other than RCTs].
    Timmer A
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):194-200. PubMed ID: 21530909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of publication of randomized controlled trials in nephrology.
    Moorthi RN; Lam A; Tangri N; Sood MM; Wagner M; Alam A
    Clin Nephrol; 2013 Oct; 80(4):280-5. PubMed ID: 23782546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-publication and publication bias in reproductive medicine: a cohort analysis.
    Lensen S; Jordan V; Showell M; Showell E; Shen V; Venetis C; Farquhar C
    Hum Reprod; 2017 Aug; 32(8):1658-1666. PubMed ID: 28854591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer.
    Lu J; Xu BB; Shen LL; Wu D; Xue Z; Zheng HL; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM; Zheng CH; Li P
    JAMA Netw Open; 2021 Sep; 4(9):e2124760. PubMed ID: 34533573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the trial outcome was associated with publication rate and time to publication.
    Song SY; Koo DH; Jung SY; Kang W; Kim EY
    J Clin Epidemiol; 2017 Apr; 84():78-84. PubMed ID: 28238789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in positive results and dissemination of randomized controlled trials in immuno-oncology.
    Xu C; Zhang S; Zhu GL; Yang KB; Zhang Y; Mao YP; Tang LL; Liu Q; Huang Y; Ma J
    Int Rev Immunol; 2023; 42(2):91-100. PubMed ID: 35712868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty percent of secondary publications of randomized controlled trials of drugs did not provide new results relative to the primary publication.
    Lai C; Sbidian E; Giraudeau B; Le Cleach L
    J Clin Epidemiol; 2020 Jan; 117():20-28. PubMed ID: 31546006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology.
    Li XQ; Yang GL; Tao KM; Zhang HQ; Zhou QH; Ling CQ
    Scand J Gastroenterol; 2013 Dec; 48(12):1474-83. PubMed ID: 24131272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reporting bias due to discrepancies between registered and published outcomes in osteoarthritis trials.
    Krsticevic M; Saric D; Saric F; Slapnicar E; Boric K; Dosenovic S; Jelicic Kadic A; Kegalj MJ; Puljak L
    J Comp Eff Res; 2019 Nov; 8(15):1265-1273. PubMed ID: 31739691
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between publicly accessible publications, registries, and protocols of phase III trials indicated persistence of selective outcome reporting.
    Zhang S; Liang F; Li W
    J Clin Epidemiol; 2017 Nov; 91():87-94. PubMed ID: 28757260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.